Rel-N-[2-[[(3R,4R)-1-[Cis-4-(1,3-Benzodioxol-5-Yl)-4-Hydroxycyclohexyl]-4-Ethoxy-3-Pyrrolidinyl]Amino]-2-Oxoethyl]-3-(Trifluoromethyl)Benzamide
98%
- Product Code: 231509
CAS:
1285539-85-6
| Molecular Weight: | 577.59 g./mol | Molecular Formula: | C₂₉H₃₄F₃N₃O₆ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature |
Product Description:
Used in pharmaceutical research as a potent and selective agonist for the glucagon-like peptide-1 (GLP-1) receptor. It is primarily investigated for the treatment of type 2 diabetes due to its ability to enhance glucose-dependent insulin secretion, suppress glucagon release, and slow gastric emptying. The compound also promotes satiety and reduces food intake, making it a candidate for obesity management. Its structure allows for improved metabolic stability and prolonged in vivo activity, supporting development as a long-acting injectable or oral antidiabetic agent. Currently, it serves as a lead compound in optimizing next-generation therapies for metabolic disorders.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿57,710.00 |
+
-
|
Rel-N-[2-[[(3R,4R)-1-[Cis-4-(1,3-Benzodioxol-5-Yl)-4-Hydroxycyclohexyl]-4-Ethoxy-3-Pyrrolidinyl]Amino]-2-Oxoethyl]-3-(Trifluoromethyl)Benzamide
Used in pharmaceutical research as a potent and selective agonist for the glucagon-like peptide-1 (GLP-1) receptor. It is primarily investigated for the treatment of type 2 diabetes due to its ability to enhance glucose-dependent insulin secretion, suppress glucagon release, and slow gastric emptying. The compound also promotes satiety and reduces food intake, making it a candidate for obesity management. Its structure allows for improved metabolic stability and prolonged in vivo activity, supporting development as a long-acting injectable or oral antidiabetic agent. Currently, it serves as a lead compound in optimizing next-generation therapies for metabolic disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :